Search results
Roche’s VABYSMO has successful Q1 sales despite Regeneron and Bayer’s EYLEA HD launch
Pharmaceutical Technology via Yahoo Finance· 21 hours agoLast week, Roche released promising first-quarter (Q1) 2024 sales figures for VABYSMO, a vascular...
Story from Associated Retina Consultants: Local group helps macular degeneration patients cope with...
The Arizona Republic· 6 days agoAccording to the Centers for Disease Control and Prevention (CDC), nearly 20 million Americans over ...
EYLEA HD shows promise in long-term clinical trials By Investing.com
Investing.com· 3 days agoHD clinical program during a series of presentations at the Association for Research in Vision and...
Dear Doctor: Can I use over-the-counter eye drops while on medications for macular degeneration?
OregonLive.com· 7 days agoROACH: I am a healthy 67-year-old female being treated with Eylea for wet age-related macular degeneration ...
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 - Ocular...
Benzinga· 20 hours agoOcular Therapeutix, Inc. OCUL "Ocular", the "Company"))), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization ...
...Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) -...
WTNH-TV New Haven· 2 days agoEluminex Biosciences (Eluminex), a privately-held biotechnology company focused on the development...
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 2 days agoAn increase in profits from Dupixent and further uptake of Eylea HD are likely to have aided...
Kodiak Sciences Inc. (NASDAQ:KOD) Given Average Rating of “Reduce” by Analysts
ETF DAILY NEWS· 23 hours agoKodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) has been assigned an average rating of “Reduce” from the seven brokerages that are currently covering the stock, Marketbeat reports. Three ...
Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends - Regeneron Pharmaceuticals...
Benzinga· 2 days agoThe company has several marketed products, including Eylea, approved for wet age-related macular degeneration ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today
